$ALTB
Alpine Auto Brokers Inc.

2022 Q4 Form 10-Q Financial Statement

#000182912622018282 Filed on October 27, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.340K $9.440K $36.03K
YoY Change -96.95% -73.8%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $9.340K $9.443K $36.03K
YoY Change -96.95% -73.79%
Operating Profit -$9.443K -$36.03K
YoY Change -73.79%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$9.340K -$9.440K -$36.03K
YoY Change -96.95% -73.8%
Income Tax
% Of Pretax Income
Net Earnings -$9.340K -$9.443K -$36.03K
YoY Change -96.95% -73.79%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$21.19 -$808.80
COMMON SHARES
Basic Shares Outstanding 445.5M shares 445.5M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $14.70K $14.70K $22.13K
YoY Change 0.0% -33.57%
Deferred Revenue
YoY Change
Short-Term Debt $29.74K $20.40K $44.18K
YoY Change -53.83%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $44.44K $35.11K $66.31K
YoY Change 202.26% -47.06%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $44.44K $35.11K $66.31K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $44.44K $35.11K $66.31K
YoY Change 202.26% -47.06%
SHAREHOLDERS EQUITY
Retained Earnings -$639.3K -$630.0K
YoY Change 4.88%
Common Stock $445.5K $445.5K
YoY Change 900.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$44.44K -$35.11K -$66.31K
YoY Change
Total Liabilities & Shareholders Equity
YoY Change

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$9.340K -$9.443K -$36.03K
YoY Change -96.95% -73.79%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$9.340K -$9.440K -$28.60K
YoY Change -33.38% -66.99%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.340K 9.440K 28.60K
YoY Change -33.38% -66.99%
NET CHANGE
Cash From Operating Activities -9.340K -9.440K -28.60K
Cash From Investing Activities
Cash From Financing Activities 9.340K 9.440K 28.60K
Net Change In Cash 0.000 0.000 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$9.340K -$9.440K -$28.60K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001642365
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Assets Current
AssetsCurrent
usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
usd
CY2022Q3 us-gaap Assets
Assets
usd
CY2021Q4 us-gaap Assets
Assets
usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
CY2022Q3 us-gaap Revenues
Revenues
usd
CY2021Q3 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2022Q1 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-204161
dei Entity Registrant Name
EntityRegistrantName
ALPINE AUTO BROKERS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
38-3970138
dei Entity Address Address Line1
EntityAddressAddressLine1
1185 Avenue of the Americas
dei Entity Address Address Line2
EntityAddressAddressLine2
3rd Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10036
dei City Area Code
CityAreaCode
646
dei Local Phone Number
LocalPhoneNumber
768 -8417
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
445500000 shares
CY2022Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
14704 usd
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
14704 usd
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
20402 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
35106 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14704 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
445500000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
445500000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44550000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44550000 shares
CY2022Q3 us-gaap Liabilities
Liabilities
35106 usd
CY2021Q4 us-gaap Liabilities
Liabilities
14704 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
10000 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
445500 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
44550 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
149347 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
540297 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-629953 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-609551 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-35106 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-14704 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9443 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36033 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20402 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38769 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
9443 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
36033 usd
us-gaap Operating Expenses
OperatingExpenses
20402 usd
us-gaap Operating Expenses
OperatingExpenses
38769 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9443 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-36033 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-20402 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-38769 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9443 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-36033 usd
us-gaap Net Income Loss
NetIncomeLoss
-20402 usd
us-gaap Net Income Loss
NetIncomeLoss
-38769 usd
CY2022Q3 altb Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.00
CY2021Q3 altb Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.00
altb Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.00
altb Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.00
CY2022Q3 altb Basic And Diluted Weighted Average Number Of Ordinary Shares
BasicAndDilutedWeightedAverageNumberOfOrdinaryShares
445500000 shares
CY2021Q3 altb Basic And Diluted Weighted Average Number Of Ordinary Shares
BasicAndDilutedWeightedAverageNumberOfOrdinaryShares
44550000 shares
altb Basic And Diluted Weighted Average Number Of Ordinary Shares
BasicAndDilutedWeightedAverageNumberOfOrdinaryShares
445500000 shares
altb Basic And Diluted Weighted Average Number Of Ordinary Shares
BasicAndDilutedWeightedAverageNumberOfOrdinaryShares
44550000 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-27539 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-1600 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-29139 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-1136 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-30275 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-36033 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-66308 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-14704 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1353 usd
altb Conversion Of Preferred Stock Shares
ConversionOfPreferredStockShares
10000000 shares
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
400950000 shares
altb Conversion Share Price
ConversionSharePrice
0.001
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-16057 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-9606 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-25663 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-9443 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-35106 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
20402 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
38769 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7425 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20402 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31344 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
20402 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
31344 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20402 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31344 usd
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-20402 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zLRwyhiJxvt6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_zA6eVUQGFGEh">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Management makes these estimates using the best information available at the time the estimates are made; however actual results could differ from those estimates. Significant items subject to such estimates and assumptions include valuation of inventory, and recoverability of carrying amount and the estimated useful lives of long-lived assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 altb Working Capital
WorkingCapital
35106 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-629953 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
445500000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
445500000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44550000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44550000 shares
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
20402 usd
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
0 usd
CY2022Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
14704 usd
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
14704 usd
CY2022Q3 us-gaap Other Commitment
OtherCommitment
0 usd
CY2021Q4 us-gaap Other Commitment
OtherCommitment
0 usd

Files In Submission

Name View Source Status
0001829126-22-018282-index-headers.html Edgar Link pending
0001829126-22-018282-index.html Edgar Link pending
0001829126-22-018282.txt Edgar Link pending
0001829126-22-018282-xbrl.zip Edgar Link pending
alpineautobro_10q.htm Edgar Link pending
alpineautobro_ex31-1.htm Edgar Link pending
alpineautobro_ex31-2.htm Edgar Link pending
alpineautobro_ex32-1.htm Edgar Link pending
alpineautobro_ex32-2.htm Edgar Link pending
altb-20220930.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
altb-20220930_def.xml Edgar Link unprocessable
altb-20220930_pre.xml Edgar Link unprocessable
altb-20220930_lab.xml Edgar Link unprocessable
alpineautobro_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
altb-20220930_cal.xml Edgar Link unprocessable